McMillan et al. in 2007 proposing the modified GPS reported a higher survival predictive value in CRP compared to hypoalbuminaemia in patients with Dukes stage B and C colorectal cancers [21]. The gene discussed is CRP; the disease is Hypoalbuminemia.